Use of surgical gamma probe for the detection of lymph node metastases in differentiated thyroid cancer

Citation
F. Lippi et al., Use of surgical gamma probe for the detection of lymph node metastases in differentiated thyroid cancer, TUMORI, 86(4), 2000, pp. 367-369
Citations number
8
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
TUMORI
ISSN journal
03008916 → ACNP
Volume
86
Issue
4
Year of publication
2000
Pages
367 - 369
Database
ISI
SICI code
0300-8916(200007/08)86:4<367:UOSGPF>2.0.ZU;2-Y
Abstract
Background: patients with differentiated thyroid cancer (DTC) after total o r near-total thyroidectomy require I-131 therapy. After surgery the persist ence of lymph node metastases in our series of patients was frequent (30%). Such patients are preferentially treated with radioiodine and shifted to s urgical reintervention when the nodal lesions persist after two I-131 treat ments. Aim: Use of an intraoperative radioactive probe (C-TraK) to allow a more ra dical surgical approach in thyroid cancer patients submitted to surgery for lymph node metastases, Methods and results: After adequate withdrawal of L-thyroxine suppressive t herapy six patients were given high I-131 doses followed by post-therapy WB S which demonstrated cervical activity in 5 patients and peri-jugular activ ity in 1. Surgery with the help of a gamma probe allowed to detect and remo ve all metastatic nodes. After excision all surgical specimens showed highe r radioactive counts with respect to the background. The post-surgical scan showed the disappearance of all areas of I-131 uptake. Histology confirmed the presence of metastatic lesions from papillary thyroid cancer. Conclusions: We conclude that the use of a gamma probe can be successful in patients with metastatic neck lesions resistant to I-131 treatment, partic ularly in patients with nonpalpable lesions.